Crowdonomics
All companies

Item 9 Labs Corp.

Operating

Healthcare · Phoenix, AZ

Estimated pre-money ⓘ
$142.4M
As of Feb 2022 · from Reg A Offering (2022) · our estimate: offering price × shares outstanding, not a stated valuation
Total raised
$13,332,946
Crowd $0 · Private $13.3M · 11 rounds since 2011

Financials

FY2010–FY2022 (no data for FY2016, FY2017) · from SEC filings · hover any figure for its source
$342K
−$3.3M
2013
$179K
−$17.1M
2014
$113K
−$4.7M
2015
2016no data
2017no data
$1.4M
−$689K
2018
$4.9M
−$9.9M
2019
$8.1M
−$12.3M
2020
$21.9M
−$10.9M
2021
$21.8M
−$31.2M
2022
RevenueNet income — beside revenue when positive, below the line when a loss

Chart shows the most recent 8 fiscal years; 3 earlier years are in the table below.

Metric
FY2010 audited
FY2011 audited
FY2012 audited
FY2013 audited
FY2014 audited
FY2015 audited
FY2018 audited
FY2019 audited
FY2020 audited
FY2021 audited
FY2022 audited
Income statement
Revenue
—
$47,984
$892,187
$341,991
$179,494
$113,022
$1,401,858
$4,933,960
$8,121,733
$21,937,227
$21,756,997
Cost of goods sold
—
$104,398
$417,781
$143,822
$115,663
$117,306
$1,018,109
$2,556,189
$4,825,959
$13,324,284
$14,445,269
Gross margin
—
-118%
53%
58%
36%
-4%
27%
48%
41%
39%
34%
Net income
-$23,112
-$37,188
-$4,087,714
-$3,325,069
-$17,082,226
-$4,740,684
-$688,721
-$9,948,638
-$12,299,657
-$10,905,772
-$31,179,053
Taxes paid
—
—
—
—
—
—
$88,826
—
-$85,984
—
$13,221
Balance sheet
Cash
$300
$192,017
$1,400
$19,942
$42,582
$41,745
$1,674,266
$574,943
$84,677
$1,454,460
$85,637
Accounts receivable
—
—
$611,370
$35,019
$3,137
$530
$97,382
$437,026
$352,598
$1,448,280
$586,270
Total assets
$20,300
$823,697
$1,139,182
$442,455
$508,656
$112,665
$5,043,677
$14,474,320
$20,663,769
$116,809,133
$110,761,619
Short-term debt
—
-$440,000
-$415,000
$18,178
—
$47,500
—
$2,300,000
$3,193,150
$4,536,002
$15,924,033
Long-term debt
—
—
$100,000
—
—
—
$1,500,000
—
$2,219,636
$14,957,399
$7,216,710
Total liabilities
$43,112
$5,000
$3,424,182
$3,380,306
$3,144,964
$5,097,377
$2,481,213
$7,137,874
$12,648,520
$30,707,690
$48,821,024
Other
Headcount
—
—
—
—
—
—
—
—
105
—
—

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$142.4M
est. pre-money
Reg A+ · Feb 2022

Dotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.

Cap table

Share counts as of Feb 23, 2022
ClassOutstandingVotes / shareShare of totalLast price
Common stock95,041,184—100.0%—

Shares outstanding over timein today's share terms

95M48M0
Sep 2011Feb 2022
Common stockRound openedSplit / conversion

Principal holders% as the filing states it, Jan 12, 2021

  • Stockbridge Enterprises LP7,377 shares13.2%of company
  • Douglas Bowden8,440,000 shares10.6%of company
  • Scottsdale6,144,712 shares7.73%of company
  • Andrew Poirier5,468,045 shares6.88%of company
  • Mark Murro III4,788,623 shares6.02%of company
  • Bryce Skalla3,177,036 shares4%of company
  • Jeffrey Rassas1,705,733 shares2.28%of company
  • Christopher Wolven288,460 shares0.36%of company
  • Michael Keskey117,647 shares0.15%of company
  • Ronald L. Miller, Jr.35,000 shares0.04%of company

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Reg A+ · Feb 2022Closedvia DALMORE GROUP LLC
Raised $0 / $42MEst. pre-money $142.4M
Raised $12.1MInvestors 122
Raised $185KInvestors 3
Raised $65KInvestors 2

Team

10 people
Andrew Bowden
Chief Executive Officer and Director
Christopher Wolven
Chief Operating Officer
Jeffrey Rassás
Chief Strategy Officer, and Director
Michael Weinberger
Chief Franchise Officer and Director
Robert E. Mikkelsen
Chief Financial Officer, Secretary, and Treasurer
Douglas Bowden
Chairman of the Board
Dr. Eric Kutscher
Director
Lawrence Taylor
Director
(Principal Executive Officer)
Show 1 more person
(Principal Financial and Accounting Officer)

Names and titles as disclosed on SEC Form 1-A. Bios and photos come from the platform campaign page and may be out of date.

  • Form 10-QAug 21, 20230001554795-23-000272
    EDGAR
  • Form 10-QMay 22, 20230001554795-23-000186
    EDGAR
  • Form 10-QFeb 14, 20230001554795-23-000037
    EDGAR
  • Form 10-KJan 13, 20230001554795-23-000012
    EDGAR
  • Form 10-QAug 15, 20220001554795-22-000307
    EDGAR
  • Form 10-QMay 16, 20220001554795-22-000191
    EDGAR
  • Form 253G2May 4, 20220001554795-22-000163
    EDGAR
  • Form QUALIFFeb 25, 20229999999994-22-000087
    EDGAR
Source: SEC EDGARCIK 0001500123DELast synced Aug 16, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.